SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 126 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $352 | -43.9% | 200 | 0.0% | 0.00% | – |
Q4 2022 | $628 | -68.6% | 200 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -98.5% | 200 | -96.8% | 0.00% | -100.0% |
Q3 2019 | $67,000 | 0.0% | 6,267 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $67,000 | +11.7% | 6,267 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $60,000 | -18.9% | 6,267 | -2.9% | 0.00% | -33.3% |
Q4 2018 | $74,000 | -35.7% | 6,451 | -5.0% | 0.01% | -25.0% |
Q3 2018 | $115,000 | +15.0% | 6,789 | -7.7% | 0.01% | 0.0% |
Q2 2018 | $100,000 | -16.0% | 7,358 | +17.0% | 0.01% | -20.0% |
Q1 2018 | $119,000 | +65.3% | 6,288 | +42.8% | 0.01% | +66.7% |
Q4 2017 | $72,000 | +1340.0% | 4,403 | +1367.7% | 0.01% | +500.0% |
Q3 2017 | $5,000 | +66.7% | 300 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
Leisure Capital Management | 43,008 | $131,000 | 0.12% |
Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |